Research output per year
Research output per year
Personal profile
Biography
Dr James Bluett (MBBS, MRes, MSc, PhD; Orchid ID: https://orcid.org/0000-0001-5062-5779) is a senior clinical lecturer and honorary consultant in rheumatology at the University of Manchester. In 2016 he completed his PhD investigating methotrexate adherence in rheumatoid arthritis and the genetics of methotrexate-pneumonitis. His research interests encompass a wide range of topics, including pharmacogenomics, treatment optimisation and adherence.
James is dedicated to training the next generation of scientists and clinicians. He supervises PhD, MSc and medical students and has served as an examiner for PhD research degrees.
In addition to his academic pursuits James is actively involved in a number of working groups and leadership positions. He is on the British Psoriatic Arthritis ConsorTium (Brit-PACT) steering committee and holds leadership roles including the Integrated Clinical Academic Training Rheumatology Academic Programme Lead
James’ research efforts have been supported by prestigious grants and collaboration with industry. He has secured substantial funding from organisations including the National Institute for Health and Care Research.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where James Bluett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A sensitive LC-MS/MS methotrexate assay capable of assessing adherence to methotrexate therapy in rheumatoid arthritis
McTaggart, M. P., Bluett, J. & Keevil, B. G., 26 Jan 2024, In: Clinical Chemistry and Laboratory Medicine. 62, 1, p. 111-117 7 p.Research output: Contribution to journal › Article › peer-review
-
Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA
BSRBR-RA Contributors Group, 14 Sept 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England).Research output: Contribution to journal › Article › peer-review
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
VROOM study investigators, Feb 2024, In: The Lancet. Rheumatology. 6, 2, p. e92-e104Research output: Contribution to journal › Article › peer-review
Open Access -
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
Ling, S. F., Ogungbenro, K., Darwich, A. S., Ariff, A. B. M., Nair, N., Bluett, J., Morgan, A. W., Isaacs, J. D., Wilson, A. G., Hyrich, K. L., Barton, A. & Plant, D., 23 May 2024, In: Pharmaceutics. 16, 6, 702.Research output: Contribution to journal › Article › peer-review
Open Access -
Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response
OUTPASS collaborators, 30 Dec 2024, In: Rheumatology Advances in Practice . 8, 1, rkae014.Research output: Contribution to journal › Article › peer-review
Open Access
Activities
-
Talking Rheumatology Live: a multidisciplinary approach to PsA
James Bluett (Speaker)
2024Activity: Talk or presentation › Invited talk › Research
-
-
Strategies to optimise adherence to methotrexate
James Bluett (Speaker)
2023Activity: Talk or presentation › Invited talk › Research
-
PhD viva external examiner Newcastle University
James Bluett (Examiner)
6 Apr 2022Activity: Examination › Research
-
Methotrexate adherence in Rheumatology
James Bluett (Speaker)
1 Oct 2019Activity: Talk or presentation › Invited talk › Research
Press/Media
-
An Exploration of Pharmacogenomics in Rheumatoid Arthritis
18/07/19
1 Media contribution
Press/Media: Expert comment
-
-
Oldham doctor develops new blood test to help arthritis patients
20/06/19
1 item of Media coverage
Press/Media: Research
Thesis
-
Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis
Bluett, J. (Author), Barton, A. (Supervisor) & Verstappen, S. (Supervisor), 31 Dec 2016Student thesis: Unknown
File